Molecule Name |
DB00256
|
DrugBank Groups |
Approved
|
Cluster No |
113
|
Smiles |
O=C2(C1(=C(O)C=CC=C1C(O)(C)C4(C2=C(O)C3(O)(C(=O)C(=C(O)C(C3C4)N(C)C)C(=O)NCNCCCCC(N)C(=O)O))))
|
Download |
mol2, pdbqt
|
TPSA |
242,98
|
Non-H Atoms |
43
|
Non-C/H Atoms |
14
|
Metal-Atoms |
0
|
Electronegative Atoms |
14
|
Stereo Centers |
6
|
Rotatable Bonds |
10
|
Rings Closures |
4
|
Small Rings |
4
|
Aromatic Rings |
1
|
Aromatic Atoms |
6
|
sp3-Atoms |
24
|
Symmetric atoms |
1
|
cLogS |
-2,591
|
MW |
602,639
|
cLogP |
-6,2313
|
HBA |
14
|
HBD |
9
|
Ro5 violations |
3
|
Druglikeness |
-10,552
|
DrugScore |
0,293837852781907
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA-
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-2,7066
|
Caco-2 Permeability 2 |
0,0859
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Substrate
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
High FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,1786
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,4468
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
III
|
Rat Acute Toxicity (LD50, mol/kg) |
2,5422
|
Carcinogenicity (Three-class) |
Non-required
|